11 patents
Utility
Spiro-lactam NMDA receptor modulators and uses thereof
14 Feb 23
Disclosed are compounds having potency in the modulation of NMDA receptor activity.
M. Amin Khan
Filed: 31 Jan 19
Utility
Spiro-lactam NMDA receptor modulators and uses thereof
20 Dec 22
Disclosed are compounds having potency in the modulation of NMDA receptor activity.
M. Amin Khan
Filed: 13 Aug 21
Utility
Spiro-lactam NMDA receptor modulators and uses thereof
29 Nov 22
Disclosed are compounds having potency in the modulation of NMDA receptor activity.
M. Amin Khan
Filed: 17 Feb 21
Utility
Spiro-lactam NMDA modulators and methods of using same
30 Aug 22
Disclosed are compounds having potency in the modulation of NMDA receptor activity.
M. Amin Khan
Filed: 4 Feb 20
Utility
Spiro-lactam NMDA receptor modulators and uses thereof
5 Jul 22
Disclosed are compounds having potency in the modulation of NMDA receptor activity.
M. Amin Khan
Filed: 1 Dec 20
Utility
Spiro-lactam NMDA receptor modulators and uses thereof
3 Aug 21
Disclosed are compounds having enhanced potency in the modulation of NMDA receptor activity.
John A. Lowe, III, M. Amin Khan
Filed: 9 Aug 19
Utility
Spiro-lactam and bis-spiro-lactam NMDA receptor modulators and uses thereof
8 Jun 21
Disclosed are compounds having potency in the modulation of NMDA receptor activity.
M. Amin Khan
Filed: 1 Aug 17
Utility
Spiro-lactam NMDA receptor modulators and uses thereof
30 Mar 21
Disclosed are compounds having potency in the modulation of NMDA receptor activity.
M. Amin Khan
Filed: 1 Aug 17
Utility
Spiro-lactam NMDA receptor modulators and uses thereof
16 Feb 21
Disclosed are compounds having potency in the modulation of NMDA receptor activity.
M. Amin Khan
Filed: 1 Aug 17
Utility
Spiro-lactam NMDA receptor modulators and uses thereof
14 Oct 19
Disclosed are compounds having enhanced potency in the modulation of NMDA receptor activity.
John A. Lowe, III, M. Amin Khan
Filed: 1 May 18
Utility
Spiro-lactam NMDA receptor modulators and uses thereof
14 Oct 19
Disclosed are compounds having enhanced potency in the modulation of NMDA receptor activity.
John A. Lowe, III, M. Amin Khan
Filed: 1 May 18
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first